Access cutting-edge mantle cell lymphoma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access mantle cell lymphoma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mantle cell lymphoma treatment provided free
This phase II trial tests how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come back (after a period of improvement) (relapsed) or that has not responded to previous treatment (refractory). Tafasitamab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Lenalidomide is in a class of medications called immunomodulatory agents. It works by helping the immune system kill cancer cells. Venetocl
Sponsor: Academic and Community Cancer Research United
Check if you qualify for this mantle cell lymphoma clinical trial in Houston, TX
If you're searching for mantle cell lymphoma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mantle cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.